Chronic Rhinosinusitis: Clinical Trials

10 trials for Chronic Rhinosinusitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 10
Phase 21Completed 1

Follow Chronic Rhinosinusitis: new trials by email Literature Review of Chronic Rhinosinusitis trials Research Report on Chronic Rhinosinusitis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps
OPN-375 - Chronic Rhinosinusitis
Phase 3CompletedOptinose US Inc.2232019-06-062023-12-21
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
OPN-375 - Chronic Rhinosinusitis
Phase 3CompletedOptinose US Inc.3322018-11-272024-05-29
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Omalizumab, Placebo - Nasal Polyps, Chronic Rhinosinusitis
Phase 3CompletedHoffmann-La Roche2492018-05-092022-04-04
Xylitol for Chronic Sinusitis
Xylitol, Saline - Chronic Rhinosinusitis, Rhinosinusitis
Phase 2 / Phase 3CompletedOchsner Health System12018-03-012023-04-07
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
Omalizumab, Placebo - Nasal Polyps, Chronic Rhinosinusitis
Phase 3CompletedHoffmann-La Roche1272017-11-212020-03-23
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Omalizumab, Placebo - Nasal Polyps, Chronic Rhinosinusitis
Phase 3CompletedHoffmann-La Roche1382017-11-152020-03-23
Sinupret Extract Coated Tablets in Chronic Rhinosinusitis
Sinupret extract coated tablets, Placebo coated tablets - Chronic Rhinosinusitis
Phase 3CompletedBionorica SE5722016-04-282018-02-28
Mitomicin C for Prevention Postoperative Endoscopic Sinus Surgery Synechia and QOL in Chronic Rhinosinusitis
Mitomicin C, Identical placebo solution - Chronic Rhinosinusitis, Postoperative Nasal Synerchia
Phase 3CompletedMahidol University2242015-03-012018-05-23
Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations
oral levofloxacin, nebulized levofloxacin - Chronic Rhinosinusitis
Phase 3CompletedUniversity of Rochester332013-10-012021-03-24
Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
Pulmozyme - Cystic Fibrosis, Chronic Rhinosinusitis
Phase 3CompletedUniversity of Jena52005-12-012014-12-04

Narrower conditions

Nasal Polyps (3)  ·  Cystic Fibrosis (1)  ·  Rhinosinusitis (1)  ·  Sinusitis (1)

Broader conditions

Respiratory Tract Diseases (5)  ·  Nose Diseases (4)  ·  Otorhinolaryngologic Diseases (4)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Polyps (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Infant, Newborn, Diseases (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Pancreatic Diseases (1)  ·  Paranasal Sinus Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Omalizumab (3)  ·  Levofloxacin (1)  ·  Mitomycin (1)  ·  Sinupret (1)  ·  Sodium Chloride (1)  ·  Xylitol (1)  ·  dornase alfa (1)

Sponsors

Hoffmann-La Roche (3)  ·  Optinose US Inc. (2)  ·  Bionorica SE (1)  ·  Mahidol University (1)  ·  Ochsner Health System (1)  ·  University of Jena (1)  ·  University of Rochester (1)

Countries

United States (7)  ·  Poland (6)  ·  Germany (4)  ·  Russia (4)  ·  United Kingdom (4)  ·  Canada (3)  ·  Czechia (3)  ·  Mexico (3)  ·  Spain (3)  ·  Ukraine (3)  ·  Belgium (2)  ·  Bulgaria (2)  ·  France (2)  ·  Georgia (2)  ·  Hungary (2)

Top investigators

Jennifer Carothers (2)  ·  John Messina (2)  ·  Jochen G. Mainz, M.D. (1)  ·  Li-Xing Man, MD, MPA, Msc (1)  ·  Pawin Numthavaj, M.D. (1)

Results publications

PMID 37951571, PMID 38197558, PMID 33548517, PMID 33710614, PMID 34382434, PMID 37214171, PMID 42647052, PMID 42692406, PMID 15023840, PMID 15316237, PMID 15510034, PMID 17405780, PMID 17882910, PMID 21994147, PMID 23378777, PMID 23785241, PMID 27394715, PMID 28390807, PMID 8281565, PMID 9755259

NIH funding

2017 (3), 2015 (1)